For research use only. Not for therapeutic Use.
Most tissues have an endogenous pool of progenitor cells to draw from upon injury. The adult heart, however, contains a limited number of undifferentiated cells and techniques to replicate these cells from other pluripotent tissues have thus far been nonselective and inefficient. Cardiogenol C is a diaminopyrimidine compound that induces the differentiation of MHC-<wbr></wbr> (myosin heavy chain) positive cardiomyocytes from embryonic stem cells with an EC<sub>50</sub> value of 0.1 µM. About 90% of embryonic stem cells treated with 0.25 µM cardiogenol C express the cardiac muscle cell specific transcription factors GATA-<wbr></wbr>4, MEF2, and Nkx2.5 and display the characteristic beating behavior of differentiated cardiomyocytes.
Catalog Number | R064361 |
CAS Number | 671225-39-1 |
Synonyms | 2-[[2-[(4-methoxyphenyl)amino]-4-pyrimidinyl]amino]-ethanol |
Molecular Formula | C13H16N4O2 • HCl |
Purity | ≥95% |
Target | β-catenin |
Storage | -20°C |
InChI | InChI=1S/C13H16N4O2.ClH/c1-19-11-4-2-10(3-5-11)16-13-15-7-6-12(17-13)14-8-9-18;/h2-7,18H,8-9H2,1H3,(H2,14,15,16,17);1H |
InChIKey | QQAHYSZVJLHCNA-UHFFFAOYSA-N |
SMILES | COC1=CC=C(NC2=NC(NCCO)=CC=N2)C=C1.Cl |
Reference | 1.Wu, X.,Ding, S.,Ding, Q., et al. Small molecules that induce cardiomyogenesis in embryonic stem cells. Journal of the American Chemical Society 126(6), 1590-1591 (2004). |